Protocol of safe vaccination against COVID-19 in patients with high risk of allergic reactions.

Jan RomantowskiJerzy KruszewskiOskar SolarskiAndrzej BantAndrzej ChciałowskiIlona PietrzykPatrycja SańpruchAleksandra GórskaMarta ChełmińskaAgata KnurowskaMarika GawinowskaEwa JassemMarek Niedoszytko

Published in: Clinical and translational allergy (2022)

Skin tests with anti-COVID-19 vaccines are a useful tool in the vaccination protocol. This protocol enables safe immunisation of high-allergy-risk patients even in cases of positive skin tests.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
end stage renal disease
ejection fraction
newly diagnosed
soft tissue
chronic kidney disease
prognostic factors
wound healing
atopic dermatitis
patient reported outcomes